市場調査レポート

商品コード

1623956

リアルワールドエビデンス分析の市場規模、シェア、成長分析、コンポーネント別、用途別、収益モデル別、展開モード別、地域別 - 産業予測、2025～2032年

Real World Evidence Analytics Market Size, Share, Growth Analysis, By Component, By Application, By Revenue Model, By Deployment Mode, By Region - Industry Forecast 2025-2032

出版日: 2025年01月02日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

リアルワールドエビデンス分析の世界市場規模は2023年に24億米ドルと評価され、2024年の25億9,000万米ドルから2032年には48億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは8.1％で成長する見通しです。

当レポートでは、償還決定、医薬品開発、市販後調査、臨床規制プロセスなど、様々な用途に不可欠なリアルワールドエビデンス（RWE）分析ソリューションの新興国市場を分析しています。これらのソリューションの主なエンドユーザーは、製薬、バイオテクノロジー、医療機器企業、ヘルスケア支払者、プロバイダーなど多岐にわたります。RWEアナリティクス市場は、ヘルスケアにおけるビッグデータの急増、価値に基づくケアへのシフト、個別化医療への注力によって活性化しています。データの複雑さと量が増加するにつれ、RWEプログラムにおける効果的な技術統合が急務となっています。その結果、多くの組織がそのスピード、柔軟性、セキュリティ、拡張性からクラウド技術を活用し、患者データの保護を強化し、インサイト生成を加速させています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

IQVIA Inc.（US）
Optum, Inc.（US）
IBM Corporation（US）
Parexel International Corporation（US）
Cognizant Technology Solutions Corporation（US）
Oracle Corporation（US）
Clinigen Group PLC（UK）
SAS Institute Inc.（US）
PPD, Inc.（US）
Syneos Health, Inc.（US）
Anthem, Inc.（US）
Change Healthcare Inc.（US）
Evidera, Inc.（US）
ICON plc（Ireland）
Flatiron Health, Inc.（US）
HealthVerity, Inc.（US）
Phesi Inc.（US）
Aetion, Inc.（US）
Medidata Solutions（US）
Clarify Health Solutions（US）

結論と推奨事項

Product Code: SQSG35G2031

Global Real World Evidence Analytics Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.59 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The report analyzes the growing market for Real-World Evidence (RWE) analytics solutions, which are essential for various applications including reimbursement decisions, drug development, post-market surveillance, and clinical regulatory processes. Key end-users of these solutions span pharmaceutical, biotechnology, medical device companies, healthcare payers, and providers. The RWE analytics market is being fueled by the surge of big data in healthcare, a shift towards value-based care, and a focus on personalized medicine. As data complexity and volume increase, there is a pressing need for effective technology integration in RWE programs. Consequently, many organizations are leveraging cloud technologies for their speed, flexibility, security, and scalability, which enhances patient data protection and accelerates insight generation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real World Evidence Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real World Evidence Analytics Market Segmental Analysis

Global Real World Evidence Analytics Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real World Evidence Analytics Market

The Global Real World Evidence Analytics market is significantly driven by the increasing elderly population, which correlates with a higher incidence of chronic diseases. This demographic trend is prompting a transition from volume-based care to value-based care models. Additionally, prolonged drug development timelines and rising costs are fueling the demand for effective RWE solutions. Moreover, enhanced research and development expenditures, alongside robust support from regulatory authorities for the adoption of real-world evidence methodologies, are further contributing to the market's expansion. Collectively, these factors are pivotal in shaping the growth trajectory of the Real World Evidence Analytics sector.

Restraints in the Global Real World Evidence Analytics Market

A major challenge facing the Global Real World Evidence Analytics market is the absence of universally accepted methodological standards and robust data processing infrastructure. This void in established guidelines for designing, conducting, analyzing, and reporting Real World Evidence (RWE) leads to skepticism about its quality and reliability. Consequently, RWE often fails to be recognized as credible enough to inform comparisons of treatment efficacy, which undermines its potential value and decreases motivation for its generation. Furthermore, this situation dissuades key stakeholders from engaging with RWE, stifling innovation and progress within the industry as a whole.

Market Trends of the Global Real World Evidence Analytics Market

The Global Real World Evidence (RWE) Analytics market is poised for significant growth as artificial intelligence (AI) becomes integral to enhancing data standards and quality control. AI applications are revolutionizing the pre-processing of real-world data (RWD), enabling pharmaceutical and biotechnology companies to accelerate insights and maximize the utility of diverse data sources. This trend is underscored by the emergence of advanced RWE technology platforms offering intelligent data processing and analysis capabilities. By leveraging AI innovations, stakeholders can improve drug research and patient outcomes while uncovering new business opportunities, ultimately fostering a more efficient and responsive healthcare ecosystem.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Real World Evidence Analytics Market Size by Component & CAGR (2025-2032)

Market Overview
Services
Data Sets
- Clinical settings data sets
- Claims data sets
- Pharmacy data sets
- Patient-powered data sets
- Registry-based data sets
- Integrated data sets

Global Real World Evidence Analytics Market Size by Application & CAGR (2025-2032)

Market Overview
Drug Development & Approvals
- Oncology
- Cardiovascular Disease
- Neurology
- Immunology
- Other Therapeutic Areas
Medical Device Development & Approvals
Post-Market Surveillance
Market Access & Reimbursement/Coverage Decision-Making
Clinical & Regulatory Decision-Making

Global Real World Evidence Analytics Market Size by Revenue Model & CAGR (2025-2032)

Market Overview
Pay Per Use (Value-Based Pricing)
Subscription

Global Real World Evidence Analytics Market Size by Deployment Mode & CAGR (2025-2032)

Market Overview
On-Premises
Cloud-Based

Global Real World Evidence Analytics Market Size by End User & CAGR (2025-2032)

Market Overview
Pharmaceutical & Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users

Global Real World Evidence Analytics Market Size & CAGR (2025-2032)

North America (Component, Application, Revenue Model, Deployment Mode, End User)
- US
- Canada
Europe (Component, Application, Revenue Model, Deployment Mode, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Application, Revenue Model, Deployment Mode, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Application, Revenue Model, Deployment Mode, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Application, Revenue Model, Deployment Mode, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optum, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBM Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cognizant Technology Solutions Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinigen Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SAS Institute Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anthem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Change Healthcare Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evidera, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flatiron Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HealthVerity, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phesi Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aetion, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medidata Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarify Health Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

リアルワールドエビデンス分析の市場規模、シェア、成長分析、コンポーネント別、用途別、収益モデル別、展開モード別、地域別 - 産業予測、2025～2032年

Real World Evidence Analytics Market Size, Share, Growth Analysis, By Component, By Application, By Revenue Model, By Deployment Mode, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

リアルワールドエビデンス分析市場規模：コンポーネント別

リアルワールドエビデンス分析市場規模：用途別

リアルワールドエビデンス分析市場規模：収益モデル別

リアルワールドエビデンス分析市場規模：展開モード別

リアルワールドエビデンス分析市場規模：エンドユーザー別

リアルワールドエビデンス分析市場規模